Medical Disposables and Supplies Limited (MDS) is reporting in audited financial results for the financial year ended March 31, 2020, Total Revenue of JA$2.48B, growing by $259M or 12% when compared to the prior year.
Commenting on the results, General Manager Kurt Boothe, noted that this was mainly attributable to a combination of an increase in product offerings, price increases, and above-average growth in the pharmaceutical division.
Gross profit of $559M for the year increased by $10M or 2% when compared to the year ended March 31, 2019, which he reported was due primarily to an increase in cost of goods sold.
The Company, he noted experienced a reduction in margin from a major supplier, which contributed to a higher than normal cost of goods sold and therefore affected the profitability of that division.
During the current year, the Company made several changes to its operations to reduce the level of inefficiencies, particularly to treat with expiring and damaged inventory, this also had an impact on profitability he reported.
MDS also reported that operating expenses of $460.2M increased by $98.3M or 27% due mainly to the costs associated with the growth in sales and talent acquisition and retention. These operational expenses include:
• Salaries, commissions, and related expenses of $244.2M, increased by $49.4M when compared to the prior year. This was due to the addition of new staff in critical areas as well as increased commercial activities.
• Legal & Professional Fees increased by $4.8M over the prior year due to the acquisition of consultancy services during the current year.
• General insurance increased $4M due to increased property, plant, and equipment.
• Delivery expenses increased by $5M
• based on increased commercial activities.
• Utility expenses increased by $2.3M over the same period last year.
Commenting further he noted that the increase in staff-related expenses was due to the activation of the Company’s long-term strategic plan to build out the expansion model which will guide the Company into the future. This, he reported, required the hiring of talent in several strategic positions.
The Company was restructured into three divisions, thereby requiring persons at the management level to oversee the operations and drive the growth in each segment.
Described as a reset year for MDS Ltd, the Company is systematically equipping itself to take on the challenges that will inevitably present themselves once the expansion takes shape.
Total non-operational expenses of $63.3M were flat when compared to March 2019.
There was a reduction in foreign exchange losses of $3.8M, offset by an increase in net finance costs of $$3.3M. This as the Company recorded $23M in Foreign exchange losses in the prior year, a trend which continued into the current year.
By October 2019, MDS had accumulated foreign exchange losses of $23M, requiring several mitigating strategies, employed to negate the effects the depreciation on the Jamaican dollar was having on the operations of the Company. By end of the current year, the Company suffered a loss of $19.6M in foreign exchange losses, he reported.
Despite this being a challenging year, the Company generated a profit after tax of approximately $35M, which was $78M below the previous year.
Total assets grew by $94M to $1.74B or 5.67% when compared to the previous year.
Inventory decreased by 12% year over year whilst receivables increased 35%, as a direct result of the increased business in the last quarter, which were reflected in the overall increase in sales revenue.
Shareholders’ equity of $834M grew by $75M or 10% over prior year as total liabilities of $908.7M grew 2% over March 2019.
In relation to Dividends, he reported that the Company distributed dividends of $0.11 per share to shareholders during the current financial year.
Q4 2020 Results
General Manager Boothe also took the opportunity to update shareholders on the results for the Quarter ended March 31, 2020 compared with the Quarter ended March 31, 2019
The Company, he noted generated an after-tax profit of $5.4M for the fourth quarter ended March 31, 2020, down significantly when compared to a year ago when profit-after-tax was $58M for the quarter.
The reduction in profit was due to higher than normal cost of goods sold coupled with higher administration, marketing and selling expenses. Several inefficiencies were detected and measures taken to correct internal processes to alleviate future losses. These measures included the recruitment of specialized skills in key areas to manage the Company’s growth and development and to reduce waste.
Sales revenue for the fourth quarter was $755.5M compared to $641.3M in the fourth quarter of the prior year, an increase of $114M or 18%. Sales in this quarter were $152.1M or 25% higher than that of the third quarter.
Gross profit for the period was $160M compared to $182.4M in the corresponding period in the previous year, a decrease of $22.4M or 12%. Gross profit in this quarter was $35.4M or 28% higher than that of the third quarter.
Total operational expenses were $147.6M compared to $98.5M, an increase of $49.1M or 50%. Operational expenses in this quarter were $41.5M or 39% higher than that of the third quarter.
Total non-operating expenses were $10.3M for the fourth quarter, compared to $15.4M, a decrease of $5.1M or 33%. Non-operational expenses in this quarter were 20% less than the third quarter.